<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37328865</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1758-9193</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>16</Day></PubDate></JournalIssue><Title>Alzheimer's research &amp; therapy</Title><ISOAbbreviation>Alzheimers Res Ther</ISOAbbreviation></Journal><ArticleTitle>Shared genetic risk loci between Alzheimer's disease and related dementias, Parkinson's disease, and amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>113</StartPage><MedlinePgn>113</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">113</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13195-023-01244-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Genome-wide association studies (GWAS) have indicated moderate genetic overlap between Alzheimer's disease (AD) and related dementias (ADRD), Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS), neurodegenerative disorders traditionally considered etiologically distinct. However, the specific genetic variants and loci underlying this overlap remain almost entirely unknown.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We leveraged state-of-the-art GWAS for ADRD, PD, and ALS. For each pair of disorders, we examined each of the GWAS hits for one disorder and tested whether they were also significant for the other disorder, applying Bonferroni correction for the number of variants tested. This approach rigorously controls the family-wise error rate for both disorders, analogously to genome-wide significance.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eleven loci with GWAS hits for one disorder were also associated with one or both of the other disorders: one with all three disorders (the MAPT/KANSL1 locus), five with ADRD and PD (near LCORL, CLU, SETD1A/KAT8, WWOX, and GRN), three with ADRD and ALS (near GPX3, HS3ST5/HDAC2/MARCKS, and TSPOAP1), and two with PD and ALS (near GAK/TMEM175 and NEK1). Two of these loci (LCORL and NEK1) were associated with an increased risk of one disorder but decreased risk of another. Colocalization analysis supported a shared causal variant between ADRD and PD at the CLU, WWOX, and LCORL loci, between ADRD and ALS at the TSPOAP1 locus, and between PD and ALS at the NEK1 and GAK/TMEM175 loci. To address the concern that ADRD is an imperfect proxy for AD and that the ADRD and PD GWAS have overlapping participants (nearly all of which are from the UK Biobank), we confirmed that all our ADRD associations had nearly identical odds ratios in an AD GWAS that excluded the UK Biobank, and all but one remained nominally significant (p&#x2009;&lt;&#x2009;0.05) for AD.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In one of the most comprehensive investigations to date of pleiotropy between neurodegenerative disorders, we identify eleven genetic risk loci shared among ADRD, PD, and ALS. These loci support lysosomal/autophagic dysfunction (GAK/TMEM175, GRN, KANSL1), neuroinflammation/immunity (TSPOAP1), oxidative stress (GPX3, KANSL1), and the DNA damage response (NEK1) as transdiagnostic processes underlying multiple neurodegenerative disorders.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wainberg</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre for Addiction and Mental Health, 250 College Street, Toronto, M5T 1R8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrews</LastName><ForeName>Shea J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Psychiatry &amp; Behavioral Sciences, University of California San Francisco, San Francisco, 94143, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tripathy</LastName><ForeName>Shreejoy J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Centre for Addiction and Mental Health, 250 College Street, Toronto, M5T 1R8, Canada. shreejoy.tripathy@camh.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Sciences, University of Toronto, Toronto, M5S 1A8, Canada. shreejoy.tripathy@camh.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of Toronto, Toronto, M5T 1R8, Canada. shreejoy.tripathy@camh.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology, University of Toronto, Toronto, M5S 1A8, Canada. shreejoy.tripathy@camh.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R00 AG070109</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Alzheimers Res Ther</MedlineTA><NlmUniqueID>101511643</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Genome-wide association studies</Keyword><Keyword MajorTopicYN="N">Parkinson&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Pleiotropy</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>17</Day><Hour>5</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>16</Day><Hour>23</Hour><Minute>40</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37328865</ArticleId><ArticleId IdType="pmc">PMC10273745</ArticleId><ArticleId IdType="doi">10.1186/s13195-023-01244-3</ArticleId><ArticleId IdType="pii">10.1186/s13195-023-01244-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brittany N. Dugger DWD. Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol. 2017;9(7). 10.1101/cshperspect.a028035.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5495060</ArticleId><ArticleId IdType="pubmed">28062563</ArticleId></ArticleIdList></Reference><Reference><Citation>De Jager PL, Yang HS, Bennett DA. Deconstructing and targeting the genomic architecture of human neurodegeneration. Nat Neurosci. 2018;21(10):1310&#x2013;1317. doi: 10.1038/s41593-018-0240-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0240-z</ArticleId><ArticleId IdType="pubmed">30258235</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyle PA, Yu L, Wilson RS, Leurgans SE, Schneider JA, Bennett DA. Person-specific contribution of neuropathologies to cognitive loss in old age. Ann Neurol. 2018;83(1). 10.1002/ana.25123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5876116</ArticleId><ArticleId IdType="pubmed">29244218</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornblath EJ, Robinson JL, Irwin DJ, et al. Defining and predicting transdiagnostic categories of neurodegenerative disease. Nature Biomedical Engineering. 2020;4(8):787&#x2013;800. doi: 10.1038/s41551-020-0593-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41551-020-0593-y</ArticleId><ArticleId IdType="pmc">PMC7946378</ArticleId><ArticleId IdType="pubmed">32747831</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed RM, Devenney EM, Irish M, et al. Neuronal network disintegration: common pathways linking neurodegenerative diseases. J Neurol Neurosurg Psychiatry. 2016;87(11):1234&#x2013;1241. doi: 10.1136/jnnp-2014-308350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2014-308350</ArticleId><ArticleId IdType="pmc">PMC5099318</ArticleId><ArticleId IdType="pubmed">27172939</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganguly G, Chakrabarti S, Chatterjee U, Saso L. Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer&#x2019;s disease and Parkinson&#x2019;s disease. Drug Des Devel Ther. 2017;11. 10.2147/DDDT.S130514.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5358994</ArticleId><ArticleId IdType="pubmed">28352155</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan L, Cookson MR, Petrucelli L, La Spada AR. Converging pathways in neurodegeneration, from genetics to mechanisms. Nat Neurosci. 2018;21(10):1300. doi: 10.1038/s41593-018-0237-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0237-7</ArticleId><ArticleId IdType="pmc">PMC6278826</ArticleId><ArticleId IdType="pubmed">30258237</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan SH, Karri V, Tay N, et al. Emerging pathways to neurodegeneration: dissecting the critical molecular mechanisms in Alzheimer&#x2019;s disease, Parkinson&#x2019;s disease. Biomed Pharmacother. 2019;111:765&#x2013;777. doi: 10.1016/j.biopha.2018.12.101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.12.101</ArticleId><ArticleId IdType="pubmed">30612001</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsh AP. Molecular mechanisms of proteinopathies across neurodegenerative disease: a review. Neurological Research and Practice. 2019;1(1):1&#x2013;7. doi: 10.1186/s42466-019-0039-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42466-019-0039-8</ArticleId><ArticleId IdType="pmc">PMC7650105</ArticleId><ArticleId IdType="pubmed">33324900</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellou E, Stevenson-Hoare J, Escott-Price V. Polygenic risk and pleiotropy in neurodegenerative diseases. Neurobiol Dis. 2020;142. 10.1016/j.nbd.2020.104953.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7378564</ArticleId><ArticleId IdType="pubmed">32445791</ArticleId></ArticleIdList></Reference><Reference><Citation>Anttila V, Bulik-Sullivan B, Finucane HK, et al. Analysis of shared heritability in common disorders of the brain. Science. 2018;360(6395). 10.1126/science.aap8757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6097237</ArticleId><ArticleId IdType="pubmed">29930110</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamza TH, Zabetian CP, Tenesa A, et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson&#x2019;s disease. Nat Genet. 2010;42(9):781&#x2013;785. doi: 10.1038/ng.642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.642</ArticleId><ArticleId IdType="pmc">PMC2930111</ArticleId><ArticleId IdType="pubmed">20711177</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert JC, Ibrahim-Verbaas CA, Harold D, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer&#x2019;s disease. Nat Genet. 2013;45(12):1452. doi: 10.1038/ng.2802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2802</ArticleId><ArticleId IdType="pmc">PMC3896259</ArticleId><ArticleId IdType="pubmed">24162737</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari R, Hernandez DG, Nalls MA, et al. Frontotemporal dementia and its subtypes: a genome-wide association study. Lancet Neurol. 2014;13(7):686. doi: 10.1016/S1474-4422(14)70065-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70065-1</ArticleId><ArticleId IdType="pmc">PMC4112126</ArticleId><ArticleId IdType="pubmed">24943344</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W, van der Spek RAA, Bakker MK, et al. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat Genet. 2021;53(12):1636&#x2013;1648. doi: 10.1038/s41588-021-00973-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00973-1</ArticleId><ArticleId IdType="pmc">PMC8648564</ArticleId><ArticleId IdType="pubmed">34873335</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim&#xf3;n-S&#xe1;nchez J, Schulte C, Bras JM, et al. Genome-wide association study reveals genetic risk underlying Parkinson&#x2019;s disease. Nat Genet. 2009;41(12):1308&#x2013;1312. doi: 10.1038/ng.487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.487</ArticleId><ArticleId IdType="pmc">PMC2787725</ArticleId><ArticleId IdType="pubmed">19915575</ArticleId></ArticleIdList></Reference><Reference><Citation>Desikan RS, Schork AJ, Wang Y, et al. Genetic overlap between Alzheimer&#x2019;s disease and Parkinson&#x2019;s disease at the MAPT locus. Mol Psychiatry. 2015;20(12):1588. doi: 10.1038/mp.2015.6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2015.6</ArticleId><ArticleId IdType="pmc">PMC4539304</ArticleId><ArticleId IdType="pubmed">25687773</ArticleId></ArticleIdList></Reference><Reference><Citation>Jun G, Ibrahim-Verbaas CA, Vronskaya M, et al. A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry. 2015;21(1):108&#x2013;117. doi: 10.1038/mp.2015.23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2015.23</ArticleId><ArticleId IdType="pmc">PMC4573764</ArticleId><ArticleId IdType="pubmed">25778476</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JA, Chen Z, Won H, et al. Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases. Mol Neurodegener. 2018;13(1):1&#x2013;11. doi: 10.1186/s13024-018-0270-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0270-8</ArticleId><ArticleId IdType="pmc">PMC6083608</ArticleId><ArticleId IdType="pubmed">30089514</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Deerlin VM, Sleiman PMA, Martinez-Lage M, et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet. 2010;42(3):234. doi: 10.1038/ng.536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.536</ArticleId><ArticleId IdType="pmc">PMC2828525</ArticleId><ArticleId IdType="pubmed">20154673</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Sun JY, Zhang Y, et al. rs1990622 variant associates with Alzheimer&#x2019;s disease and regulates TMEM106B expression in human brain tissues. BMC Med. 2021;19(1):1&#x2013;10. doi: 10.1186/s12916-020-01883-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01883-5</ArticleId><ArticleId IdType="pmc">PMC7814705</ArticleId><ArticleId IdType="pubmed">33461566</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellenguez C, K&#xfc;&#xe7;&#xfc;kali F, Jansen IE, et al. New insights into the genetic etiology of Alzheimer&#x2019;s disease and related dementias. Nat Genet. 2022;54:412&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005347</ArticleId><ArticleId IdType="pubmed">35379992</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalls MA, Blauwendraat C, Sargent L, et al. Evidence for GRN connecting multiple neurodegenerative diseases. Brain Communications. 2021;3(2). 10.1093/braincomms/fcab095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8134835</ArticleId><ArticleId IdType="pubmed">34693284</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreassen OA, Thompson WK, Schork AJ, et al. Improved detection of common variants associated with schizophrenia and bipolar disorder using pleiotropy-informed conditional false discovery rate. PLoS Genet. 2013;9(4):e1003455. doi: 10.1371/journal.pgen.1003455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1003455</ArticleId><ArticleId IdType="pmc">PMC3636100</ArticleId><ArticleId IdType="pubmed">23637625</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari R, Wang Y, Vandrovcova J, et al. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer&#x2019;s and Parkinson&#x2019;s diseases. J Neurol Neurosurg Psychiatry. 2017;88(2):152&#x2013;164. doi: 10.1136/jnnp-2016-314411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-314411</ArticleId><ArticleId IdType="pmc">PMC5237405</ArticleId><ArticleId IdType="pubmed">27899424</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokoyama JS, Karch CM, Fan CC, et al. Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia. Acta Neuropathol. 2017;133(5):825. doi: 10.1007/s00401-017-1693-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1693-y</ArticleId><ArticleId IdType="pmc">PMC5429027</ArticleId><ArticleId IdType="pubmed">28271184</ArticleId></ArticleIdList></Reference><Reference><Citation>Karch CM, Wen N, Fan CC, et al. Selective genetic overlap between amyotrophic lateral sclerosis and diseases of the frontotemporal dementia spectrum. JAMA Neurol. 2018;75(7):860&#x2013;875. doi: 10.1001/jamaneurol.2018.0372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2018.0372</ArticleId><ArticleId IdType="pmc">PMC6043387</ArticleId><ArticleId IdType="pubmed">29630712</ArticleId></ArticleIdList></Reference><Reference><Citation>Brzyski D, Peterson CB, Sobczyk P, Cand&#xe8;s EJ, Bogdan M, Sabatti C. Controlling the rate of GWAS false discoveries. Genetics. 2017;205(1):61. doi: 10.1534/genetics.116.193987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.116.193987</ArticleId><ArticleId IdType="pmc">PMC5223524</ArticleId><ArticleId IdType="pubmed">27784720</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalls MA, Blauwendraat C, Vallerga CL, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson&#x2019;s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2019;18(12). 10.1016/S1474-4422(19)30320-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8422160</ArticleId><ArticleId IdType="pubmed">31701892</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunkle BW, Grenier-Boley B, Sims R, et al. Genetic meta-analysis of diagnosed Alzheimer&#x2019;s disease identifies new risk loci and implicates A&#x3b2;, tau, immunity and lipid processing. Nat Genet. 2019;51(3):414&#x2013;430. doi: 10.1038/s41588-019-0358-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-019-0358-2</ArticleId><ArticleId IdType="pmc">PMC6463297</ArticleId><ArticleId IdType="pubmed">30820047</ArticleId></ArticleIdList></Reference><Reference><Citation>Bycroft C, Freeman C, Petkova D, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562(7726):203&#x2013;209. doi: 10.1038/s41586-018-0579-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0579-z</ArticleId><ArticleId IdType="pmc">PMC6786975</ArticleId><ArticleId IdType="pubmed">30305743</ArticleId></ArticleIdList></Reference><Reference><Citation>Buniello A, MacArthur JAL, Cerezo M, et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 2019;47(D1). 10.1093/nar/gky1120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323933</ArticleId><ArticleId IdType="pubmed">30445434</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulik-Sullivan B, Finucane HK, Anttila V, et al. An atlas of genetic correlations across human diseases and traits. Nat Genet. 2015;47(11):1236&#x2013;1241. doi: 10.1038/ng.3406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3406</ArticleId><ArticleId IdType="pmc">PMC4797329</ArticleId><ArticleId IdType="pubmed">26414676</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning Z, Pawitan Y, Shen X. High-definition likelihood inference of genetic correlations across human complex traits. Nat Genet. 2020;52(8):859&#x2013;864. doi: 10.1038/s41588-020-0653-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-020-0653-y</ArticleId><ArticleId IdType="pubmed">32601477</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Q, Li B, Ou D, et al. A powerful approach to estimating annotation-stratified genetic covariance via GWAS summary statistics. Am J Hum Genet. 2017;101(6):939&#x2013;964. doi: 10.1016/j.ajhg.2017.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2017.11.001</ArticleId><ArticleId IdType="pmc">PMC5812911</ArticleId><ArticleId IdType="pubmed">29220677</ArticleId></ArticleIdList></Reference><Reference><Citation>Auton A, Brooks LD, Durbin RM, et al. A global reference for human genetic variation. Nature. 2015;526(7571). 10.1038/nature15393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4750478</ArticleId><ArticleId IdType="pubmed">26432245</ArticleId></ArticleIdList></Reference><Reference><Citation>Priv&#xe9; F, Arbel J, Aschard H, Vilhj&#xe1;lmsson BJ. Identifying and correcting for misspecifications in GWAS summary statistics and polygenic scores. bioRxiv. Published online April 13, 2022:2021.03.29.437510. 10.1101/2021.03.29.437510.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9465343</ArticleId><ArticleId IdType="pubmed">36105883</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Rosen JD, Sun Q, et al. TOP-LD: a tool to explore linkage disequilibrium with TOPMed whole-genome sequence data. Am J Hum Genet. 2022. 10.1016/j.ajhg.2022.04.006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9247832</ArticleId><ArticleId IdType="pubmed">35504290</ArticleId></ArticleIdList></Reference><Reference><Citation>Taliun D, Harris DN, Kessler MD, et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. Nature. 2021;590(7845):290&#x2013;299. doi: 10.1038/s41586-021-03205-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03205-y</ArticleId><ArticleId IdType="pmc">PMC7875770</ArticleId><ArticleId IdType="pubmed">33568819</ArticleId></ArticleIdList></Reference><Reference><Citation>Dmitrienko A, Wiens BL, Tamhane AC, Wang X. Tree-structured gatekeeping tests in clinical trials with hierarchically ordered multiple objectives. Stat Med. 2007;26(12). 10.1002/sim.2716.</Citation><ArticleIdList><ArticleId IdType="pubmed">17054103</ArticleId></ArticleIdList></Reference><Reference><Citation>Giambartolomei C, Vukcevic D, Schadt EE, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10(5):e1004383. doi: 10.1371/journal.pgen.1004383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1004383</ArticleId><ArticleId IdType="pmc">PMC4022491</ArticleId><ArticleId IdType="pubmed">24830394</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomaz Berisa JKP. Approximately independent linkage disequilibrium blocks in human populations. Bioinformatics. 2016;32(2):283. doi: 10.1093/bioinformatics/btv546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btv546</ArticleId><ArticleId IdType="pmc">PMC4731402</ArticleId><ArticleId IdType="pubmed">26395773</ArticleId></ArticleIdList></Reference><Reference><Citation>Wingo TS, Liu Y, Gerasimov ES, et al. Shared mechanisms across the major psychiatric and neurodegenerative diseases. Nat Commun. 2022;13(1):4314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9325708</ArticleId><ArticleId IdType="pubmed">35882878</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen IE, Savage JE, Watanabe K, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer&#x2019;s disease risk. Nat Genet. 2019;51(3):404&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6836675</ArticleId><ArticleId IdType="pubmed">30617256</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster EM, Dangla-Valls A, Lovestone S, Ribe EM, Buckley NJ. Clusterin in Alzheimer&#x2019;s disease: mechanisms, genetics, and lessons from other pathologies. Front Neurosci. 2019;0. 10.3389/fnins.2019.00164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6403191</ArticleId><ArticleId IdType="pubmed">30872998</ArticleId></ArticleIdList></Reference><Reference><Citation>Bettens K, Brouwers N, Engelborghs S, et al. Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer risk. Mol Neurodegener. 2012;7. 10.1186/1750-1326-7-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3296573</ArticleId><ArticleId IdType="pubmed">22248099</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippini A, Mutti V, Faustini G, et al. Extracellular clusterin limits the uptake of &#x3b1;-synuclein fibrils by murine and human astrocytes. Glia. 2021;69(3):681. doi: 10.1002/glia.23920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23920</ArticleId><ArticleId IdType="pmc">PMC7821254</ArticleId><ArticleId IdType="pubmed">33045109</ArticleId></ArticleIdList></Reference><Reference><Citation>Kummeling J, Stremmelaar DE, Raun N, et al. Characterization of SETD1A haploinsufficiency in humans and Drosophila defines a novel neurodevelopmental syndrome. Mol Psychiatry. 2020;26(6):2013&#x2013;2024. doi: 10.1038/s41380-020-0725-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-020-0725-5</ArticleId><ArticleId IdType="pubmed">32346159</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Ghorbani M, Weisz-Hubshman M, et al. Lysine acetyltransferase 8 is involved in cerebral development and syndromic intellectual disability. J Clin Invest. 2020;130(3):1431. doi: 10.1172/JCI131145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI131145</ArticleId><ArticleId IdType="pmc">PMC7269600</ArticleId><ArticleId IdType="pubmed">31794431</ArticleId></ArticleIdList></Reference><Reference><Citation>F&#xfc;llgrabe J, Lynch-Day MA, Heldring N, et al. The histone H4 lysine 16 acetyltransferase hMOF regulates the outcome of autophagy. Nature. 2013;500(7463):468. doi: 10.1038/nature12313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12313</ArticleId><ArticleId IdType="pmc">PMC4006103</ArticleId><ArticleId IdType="pubmed">23863932</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein AD, Mazzulli JR. Is Parkinson&#x2019;s disease a lysosomal disorder? Brain. 2018;141(8):2255&#x2013;2262. doi: 10.1093/brain/awy147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy147</ArticleId><ArticleId IdType="pmc">PMC6061679</ArticleId><ArticleId IdType="pubmed">29860491</ArticleId></ArticleIdList></Reference><Reference><Citation>Soutar MPM, Melandri D, O&#x2019;Callaghan B, et al. Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson&#x2019;s disease at Chr16q11.2 and on the MAPT H1 allele. bioRxiv. 2021. 10.1101/2020.01.06.896241.</Citation></Reference><Reference><Citation>Backman JD, Li AH, Marcketta A, et al. Exome sequencing and analysis of 454,787 UK Biobank participants. Nature. 2021;599(7886):628&#x2013;634. doi: 10.1038/s41586-021-04103-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04103-z</ArticleId><ArticleId IdType="pmc">PMC8596853</ArticleId><ArticleId IdType="pubmed">34662886</ArticleId></ArticleIdList></Reference><Reference><Citation>Frankish A, Diekhans M, Jungreis I, et al. GENCODE 2021. Nucleic Acids Res. 2021;49(D1). 10.1093/nar/gkaa1087.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7778937</ArticleId><ArticleId IdType="pubmed">33270111</ArticleId></ArticleIdList></Reference><Reference><Citation>Sze CI, Su M, Pugazhenthi S, et al. Down-regulation of WW domain-containing oxidoreductase induces Tau phosphorylation in vitro. A potential role in Alzheimer&#x2019;s disease. J Biol Chem. 2004;279(29):30498&#x2013;30506. doi: 10.1074/jbc.M401399200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M401399200</ArticleId><ArticleId IdType="pubmed">15126504</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang JY, Lee MH, Lin SR, et al. Trafficking protein particle complex 6A delta (TRAPPC6A&#x394;) is an extracellular plaque-forming protein in the brain. Oncotarget. 2015;6(6):3578. doi: 10.18632/oncotarget.2876.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.2876</ArticleId><ArticleId IdType="pmc">PMC4414138</ArticleId><ArticleId IdType="pubmed">25650666</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo CP, Hsu LJ, Li MY, et al. MPP+-induced neuronal death in rats involves tyrosine 33 phosphorylation of WW domain-containing oxidoreductase WOX1. Eur J Neurosci. 2008;27(7). 10.1111/j.1460-9568.2008.06139.x.</Citation><ArticleIdList><ArticleId IdType="pubmed">18371080</ArticleId></ArticleIdList></Reference><Reference><Citation>Root J, Merino P, Nuckols A, Johnson M, Kukar T. Lysosome dysfunction as a cause of neurodegenerative diseases: lessons from frontotemporal dementia and amyotrophic lateral sclerosis. Neurobiol Dis. 2021;154. 10.1016/j.nbd.2021.105360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8113138</ArticleId><ArticleId IdType="pubmed">33812000</ArticleId></ArticleIdList></Reference><Reference><Citation>Fyfe I. Potential gene therapy for FTD. Nat Rev Neurol. 2020;16(11):600&#x2013;600. doi: 10.1038/s41582-020-00423-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-00423-2</ArticleId><ArticleId IdType="pubmed">33009521</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao AW, McKay A, Singh PP, Brunet A, Huang EJ. Progranulin, lysosomal regulation and neurodegenerative disease. Nat Rev Neurosci. 2017;18(6):325&#x2013;333. doi: 10.1038/nrn.2017.36.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2017.36</ArticleId><ArticleId IdType="pmc">PMC6040832</ArticleId><ArticleId IdType="pubmed">28435163</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis SE, Roth JR, Aljabi Q, et al. Delivering progranulin to neuronal lysosomes protects against excitotoxicity. J Biol Chem. 2021;297(3). 10.1016/j.jbc.2021.100993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8379502</ArticleId><ArticleId IdType="pubmed">34298019</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W, Han SD, Zhang C, et al. The FAM171A2 gene is a key regulator of progranulin expression and modifies the risk of multiple neurodegenerative diseases. Sci Adv. 2020;6(43). 10.1126/sciadv.abb3063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577723</ArticleId><ArticleId IdType="pubmed">33087363</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan L, Meng L, He M, Zhang Z. Tau in the pathophysiology of Parkinson&#x2019;s disease. J Mol Neurosci. 2021;71(11):2179&#x2013;2191. doi: 10.1007/s12031-020-01776-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-020-01776-5</ArticleId><ArticleId IdType="pmc">PMC8585831</ArticleId><ArticleId IdType="pubmed">33459970</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheikh BN, Guhathakurta S, Akhtar A. The non-specific lethal (NSL) complex at the crossroads of transcriptional control and cellular homeostasis. EMBO Rep. 2019;20(7):e47630. doi: 10.15252/embr.201847630.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201847630</ArticleId><ArticleId IdType="pmc">PMC6607013</ArticleId><ArticleId IdType="pubmed">31267707</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Lu D, Yao C, et al. Kansl1 haploinsufficiency impairs autophagosome-lysosome fusion and links autophagic dysfunction with Koolen-de Vries syndrome in mice. Nat Commun. 2022;13(1):1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8854428</ArticleId><ArticleId IdType="pubmed">35177641</ArticleId></ArticleIdList></Reference><Reference><Citation>Linda K, Lewerissa EI, Verboven AHA, et al. Imbalanced autophagy causes synaptic deficits in a human model for neurodevelopmental disorders. Autophagy. 2022;18(2):423&#x2013;442. doi: 10.1080/15548627.2021.1936777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2021.1936777</ArticleId><ArticleId IdType="pmc">PMC8942553</ArticleId><ArticleId IdType="pubmed">34286667</ArticleId></ArticleIdList></Reference><Reference><Citation>Benyamin B, He J, Zhao Q, et al. Cross-ethnic meta-analysis identifies association of the GPX3-TNIP1 locus with amyotrophic lateral sclerosis. Nat Commun. 2017;8(1):1&#x2013;7. doi: 10.1038/s41467-017-00471-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00471-1</ArticleId><ArticleId IdType="pmc">PMC5606989</ArticleId><ArticleId IdType="pubmed">28931804</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362(6415). 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka H, Shimazawa M, Takata M, et al. ITIH4 and Gpx3 are potential biomarkers for amyotrophic lateral sclerosis. J Neurol. 2013;260(7). 10.1007/s00415-013-6877-3.</Citation><ArticleIdList><ArticleId IdType="pubmed">23436019</ArticleId></ArticleIdList></Reference><Reference><Citation>Restuadi R, Steyn FJ, Kabashi E, et al. Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3/TNIP1. Genome Med. 2022;14(1):1&#x2013;22. doi: 10.1186/s13073-021-01006-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-021-01006-6</ArticleId><ArticleId IdType="pmc">PMC8767698</ArticleId><ArticleId IdType="pubmed">35042540</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauthier-Kemper A, Alonso MS, S&#xfc;ndermann F, et al. Annexins A2 and A6 interact with the extreme N terminus of tau and thereby contribute to tau&#x2019;s axonal localization. J Biol Chem. 2018;293(21):8065. doi: 10.1074/jbc.RA117.000490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA117.000490</ArticleId><ArticleId IdType="pmc">PMC5971446</ArticleId><ArticleId IdType="pubmed">29636414</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahuran DJ. Biochemical consequences of mutations causing the GM2 gangliosidoses. Biochim Biophys Acta. 1999;1455(2&#x2013;3):105&#x2013;138. doi: 10.1016/S0925-4439(99)00074-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0925-4439(99)00074-5</ArticleId><ArticleId IdType="pubmed">10571007</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma&#xef;za A, Chantepie S, Vera C, et al. The role of heparan sulfates in protein aggregation and their potential impact on neurodegeneration. FEBS Lett. 2018;592(23):3806&#x2013;3818. doi: 10.1002/1873-3468.13082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.13082</ArticleId><ArticleId IdType="pubmed">29729013</ArticleId></ArticleIdList></Reference><Reference><Citation>Stopschinski BE, Holmes BB, Miller GM, et al. Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau versus &#x3b1;-synuclein and &#x3b2;-amyloid aggregates. J Biol Chem. 2018;293(27):10826. doi: 10.1074/jbc.RA117.000378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA117.000378</ArticleId><ArticleId IdType="pmc">PMC6036193</ArticleId><ArticleId IdType="pubmed">29752409</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Zhu Y, Song X, et al. Rare 3-O-sulfation of heparan sulfate enhances tau interaction and cellular uptake. Angew Chem Int Ed Engl. 2020;59(5):1818. doi: 10.1002/anie.201913029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201913029</ArticleId><ArticleId IdType="pmc">PMC6982596</ArticleId><ArticleId IdType="pubmed">31692167</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan JS, Haggarty SJ, Giacometti E, et al. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature. 2009;459(7243):55&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3498958</ArticleId><ArticleId IdType="pubmed">19424149</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xe4;ff J, Rei D, Guan JS, et al. An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature. 2012;483(7388):222&#x2013;226. doi: 10.1038/nature10849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10849</ArticleId><ArticleId IdType="pmc">PMC3498952</ArticleId><ArticleId IdType="pubmed">22388814</ArticleId></ArticleIdList></Reference><Reference><Citation>Didonna A, Opal P. The promise and perils of HDAC inhibitors in neurodegeneration. Ann Clin Transl Neurol. 2015;2(1):79. doi: 10.1002/acn3.147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.147</ArticleId><ArticleId IdType="pmc">PMC4301678</ArticleId><ArticleId IdType="pubmed">25642438</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossaert E, Pollari E, Jaspers T, et al. Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model. Acta Neuropathol Commun. 2019;7(1):1&#x2013;19. doi: 10.1186/s40478-019-0750-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0750-2</ArticleId><ArticleId IdType="pmc">PMC6612190</ArticleId><ArticleId IdType="pubmed">31277703</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagawa K, Homma H, Saito A, et al. Comprehensive phosphoproteome analysis unravels the core signaling network that initiates the earliest synapse pathology in preclinical Alzheimer&#x2019;s disease brain. Hum Mol Genet. 2015;24(2). 10.1093/hmg/ddu475.</Citation><ArticleIdList><ArticleId IdType="pubmed">25231903</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita K, Motoki K, Tagawa K, et al. HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer&#x2019;s disease. Sci Rep. 2016;6(1):1&#x2013;15. doi: 10.1038/srep31895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep31895</ArticleId><ArticleId IdType="pmc">PMC4997258</ArticleId><ArticleId IdType="pubmed">27557632</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka H, Homma H, Fujita K, et al. YAP-dependent necrosis occurs in early stages of Alzheimer&#x2019;s disease and regulates mouse model pathology. Nat Commun. 2020;11(1):1&#x2013;22. doi: 10.1038/s41467-020-14353-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-14353-6</ArticleId><ArticleId IdType="pmc">PMC6981281</ArticleId><ArticleId IdType="pubmed">31980612</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita K, Homma H, Kondo K, et al. Ser46-phosphorylated MARCKS is a marker of neurite degeneration at the pre-aggregation stage in PD/DLB pathology. eNeuro. 2018;5(4). 10.1523/ENEURO.0217-18.2018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6140116</ArticleId><ArticleId IdType="pubmed">30225354</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrozziello T, Bordt EA, Mills AN, et al. Targeting tau mitigates mitochondrial fragmentation and oxidative stress in amyotrophic lateral sclerosis. Mol Neurobiol. 2021;59(1):683&#x2013;702. doi: 10.1007/s12035-021-02557-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02557-w</ArticleId><ArticleId IdType="pubmed">34757590</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrozziello T, Amaral AC, Dujardin S, et al. Novel genetic variants in MAPT and alterations in tau phosphorylation in amyotrophic lateral sclerosis post-mortem motor cortex and cerebrospinal fluid. Brain Pathol. 2022;32(2):e13035. doi: 10.1111/bpa.13035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.13035</ArticleId><ArticleId IdType="pmc">PMC8877756</ArticleId><ArticleId IdType="pubmed">34779076</ArticleId></ArticleIdList></Reference><Reference><Citation>Gali&#xe8;gue S, Jbilo O, Combes T, et al. Cloning and characterization of PRAX-1. A new protein that specifically interacts with the peripheral benzodiazepine receptor. J Biol Chem. 1999;274(5). 10.1074/jbc.274.5.2938.</Citation><ArticleIdList><ArticleId IdType="pubmed">9915832</ArticleId></ArticleIdList></Reference><Reference><Citation>Rupprecht R, Papadopoulos V, Rammes G, et al. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov. 2010;9(12):971&#x2013;988. doi: 10.1038/nrd3295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd3295</ArticleId><ArticleId IdType="pubmed">21119734</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivash L, O&#x2019;Brien TJ. Imaging microglial activation with TSPO PET: lighting up neurologic diseases? J Nucl Med. 2016;57(2):165&#x2013;168. doi: 10.2967/jnumed.114.141713.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.114.141713</ArticleId><ArticleId IdType="pubmed">26697963</ArticleId></ArticleIdList></Reference><Reference><Citation>Barron AM, Garcia-Segura LM, Caruso D, et al. Ligand for translocator protein reverses Pathology in a mouse model of Alzheimer&#x2019;s disease. J Neurosci. 2013;33(20):8891. doi: 10.1523/JNEUROSCI.1350-13.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1350-13.2013</ArticleId><ArticleId IdType="pmc">PMC3733563</ArticleId><ArticleId IdType="pubmed">23678130</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairley LH, Sahara N, Aoki I, et al. Neuroprotective effect of mitochondrial translocator protein ligand in a mouse model of tauopathy. J Neuroinflammation. 2021;18(1):1&#x2013;13. doi: 10.1186/s12974-021-02122-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02122-1</ArticleId><ArticleId IdType="pmc">PMC7980620</ArticleId><ArticleId IdType="pubmed">33740987</ArticleId></ArticleIdList></Reference><Reference><Citation>Beilina A, Rudenko IN, Kaganovich A, et al. From the cover: unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease. Proc Natl Acad Sci U S A. 2014;111(7):2626. doi: 10.1073/pnas.1318306111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1318306111</ArticleId><ArticleId IdType="pmc">PMC3932908</ArticleId><ArticleId IdType="pubmed">24510904</ArticleId></ArticleIdList></Reference><Reference><Citation>Song L, He Y, Ou J, et al. Auxilin underlies progressive locomotor deficits and dopaminergic neuron loss in a Drosophila model of Parkinson&#x2019;s disease. Cell Rep. 2017;18(5). 10.1016/j.celrep.2017.01.005.</Citation><ArticleIdList><ArticleId IdType="pubmed">28147270</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Wang L, Yi S, et al. Cyclin-G-associated kinase GAK/Aux orchestrates glial autophagy via Atg9 phosphorylation in Parkinson&#x2019;s disease. bioRxiv. 2021. 10.1101/2021.08.16.456579.</Citation></Reference><Reference><Citation>Jinn S, Drolet RE, Cramer PE, et al. TMEM175 deficiency impairs lysosomal and mitochondrial function and increases &#x3b1;-synuclein aggregation. Proc Natl Acad Sci U S A. 2017;114(9):2389&#x2013;2394. doi: 10.1073/pnas.1616332114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1616332114</ArticleId><ArticleId IdType="pmc">PMC5338534</ArticleId><ArticleId IdType="pubmed">28193887</ArticleId></ArticleIdList></Reference><Reference><Citation>Jinn S, Blauwendraat C, Toolan D, et al. Functionalization of the TMEM175 p.M393T variant as a risk factor for Parkinson disease. Hum Mol Genet. 2019;28(19):3244&#x2013;3254. doi: 10.1093/hmg/ddz136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddz136</ArticleId><ArticleId IdType="pmc">PMC6859430</ArticleId><ArticleId IdType="pubmed">31261387</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenna KP, van Doormaal PTC, Dekker AM, et al. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nat Genet. 2016;48(9):1037. doi: 10.1038/ng.3626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3626</ArticleId><ArticleId IdType="pmc">PMC5560030</ArticleId><ArticleId IdType="pubmed">27455347</ArticleId></ArticleIdList></Reference><Reference><Citation>Kok JR, Palminha NM, Dos Santos SC, El-Khamisy SF, Ferraiuolo L. DNA damage as a mechanism of neurodegeneration in ALS and a contributor to astrocyte toxicity. Cell Mol Life Sci. 2021;78(15):5707&#x2013;5729. doi: 10.1007/s00018-021-03872-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-021-03872-0</ArticleId><ArticleId IdType="pmc">PMC8316199</ArticleId><ArticleId IdType="pubmed">34173837</ArticleId></ArticleIdList></Reference><Reference><Citation>Higelin J, Catanese A, Semelink-Sedlacek LL, et al. NEK1 loss-of-function mutation induces DNA damage accumulation in ALS patient-derived motoneurons. Stem Cell Res. 2018;30. 10.1016/j.scr.2018.06.005.</Citation><ArticleIdList><ArticleId IdType="pubmed">29929116</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Qi W, Zou C, et al. NEK1-mediated retromer trafficking promotes blood&#x2013;brain barrier integrity by regulating glucose metabolism and RIPK1 activation. Nat Commun. 2021;12(1):1&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8355301</ArticleId><ArticleId IdType="pubmed">34376696</ArticleId></ArticleIdList></Reference><Reference><Citation>Freund MK, Burch KS, Shi H, et al. Phenotype-specific enrichment of mendelian disorder genes near GWAS regions across 62 complex traits. Am J Hum Genet. 2018;103(4). 10.1016/j.ajhg.2018.08.017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6174356</ArticleId><ArticleId IdType="pubmed">30290150</ArticleId></ArticleIdList></Reference><Reference><Citation>Lumsden AL, Mulugeta A, Zhou A, Hypp&#xf6;nen E. Apolipoprotein E (APOE) genotype-associated disease risks: a phenome-wide, registry-based, case-control study utilising the UK Biobank. EBioMedicine. 2020;59. 10.1016/j.ebiom.2020.102954.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7452404</ArticleId><ArticleId IdType="pubmed">32818802</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainberg M, Sinnott-Armstrong N, Mancuso N, et al. Opportunities and challenges for transcriptome-wide association studies. Nat Genet. 2019;51(4):592&#x2013;599. doi: 10.1038/s41588-019-0385-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-019-0385-z</ArticleId><ArticleId IdType="pmc">PMC6777347</ArticleId><ArticleId IdType="pubmed">30926968</ArticleId></ArticleIdList></Reference><Reference><Citation>Stacey D, Fauman EB, Ziemek D, et al. ProGeM: a framework for the prioritization of candidate causal genes at molecular quantitative trait loci. Nucleic Acids Res. 2019;47(1):e3. doi: 10.1093/nar/gky837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky837</ArticleId><ArticleId IdType="pmc">PMC6326795</ArticleId><ArticleId IdType="pubmed">30239796</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy O, Lavalette S, Hu SJ, et al. APOE isoforms control pathogenic subretinal inflammation in age-related macular degeneration. J Neurosci. 2015;35(40):13568. doi: 10.1523/JNEUROSCI.2468-15.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2468-15.2015</ArticleId><ArticleId IdType="pmc">PMC6605380</ArticleId><ArticleId IdType="pubmed">26446211</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace C. A more accurate method for colocalisation analysis allowing for multiple causal variants. PLoS Genet. 2021;17(9):e1009440. doi: 10.1371/journal.pgen.1009440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1009440</ArticleId><ArticleId IdType="pmc">PMC8504726</ArticleId><ArticleId IdType="pubmed">34587156</ArticleId></ArticleIdList></Reference><Reference><Citation>Escott-Price V, Hardy J. Genome-wide association studies for Alzheimer&#x2019;s disease: bigger is not always better. Brain Commun. 2022;4(3):fcac125. doi: 10.1093/braincomms/fcac125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcac125</ArticleId><ArticleId IdType="pmc">PMC9155614</ArticleId><ArticleId IdType="pubmed">35663382</ArticleId></ArticleIdList></Reference><Reference><Citation>Frisoni GB, Altomare D, Thal DR, et al. The probabilistic model of Alzheimer disease: the amyloid hypothesis revised. Nat Rev Neurosci. 2021;23(1):53&#x2013;66. doi: 10.1038/s41583-021-00533-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-021-00533-w</ArticleId><ArticleId IdType="pmc">PMC8840505</ArticleId><ArticleId IdType="pubmed">34815562</ArticleId></ArticleIdList></Reference><Reference><Citation>Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145):661&#x2013;678. doi: 10.1038/nature05911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05911</ArticleId><ArticleId IdType="pmc">PMC2719288</ArticleId><ArticleId IdType="pubmed">17554300</ArticleId></ArticleIdList></Reference><Reference><Citation>Broekema RV, Bakker OB, Jonkers IH. A practical view of fine-mapping and gene prioritization in the post-genome-wide association era. Open Biol. 2020;10(1):190221. doi: 10.1098/rsob.190221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.190221</ArticleId><ArticleId IdType="pmc">PMC7014684</ArticleId><ArticleId IdType="pubmed">31937202</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>